Clinical Trial Race, Ethnicity Categories Should Match OMB’s, FDA Says
Executive Summary
FDA is recommending that clinical trial sponsors collect information on the race and ethnicity of participants using standard Office of Management & Budget categories
You may also be interested in...
FDA Genomics Guidance, Demographics Database To Improve Gender Analysis
Electronic clinical trial databases under development at FDA's Office of Women's Health will help sponsors design trials that account for gender and other demographic differences among patients, FDA Commissioner McClellan said
FDA Genomics Guidance, Demographics Database To Improve Gender Analysis
Electronic clinical trial databases under development at FDA's Office of Women's Health will help sponsors design trials that account for gender and other demographic differences among patients, FDA Commissioner McClellan said
Pediatric Trial Sponsors Should Report Minority Enrollment, GAO Says
FDA should require drug sponsors conducting pediatric trials to use specific categories in reporting the race and ethnicity of participants, GAO said